loading
Quince Therapeutics Inc stock is traded at $1.63, with a volume of 176.34K. It is up +1.24% in the last 24 hours and down -7.91% over the past month. Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
See More
Previous Close:
$1.61
Open:
$1.6
24h Volume:
176.34K
Relative Volume:
0.78
Market Cap:
$87.55M
Revenue:
-
Net Income/Loss:
$-31.39M
P/E Ratio:
-1.9405
EPS:
-0.84
Net Cash Flow:
$-18.45M
1W Performance:
-3.55%
1M Performance:
-7.91%
6M Performance:
+16.43%
1Y Performance:
+154.29%
1-Day Range:
Value
$1.584
$1.71
1-Week Range:
Value
$1.584
$1.71
52-Week Range:
Value
$0.61
$2.45

Quince Therapeutics Inc Stock (QNCX) Company Profile

Name
Name
Quince Therapeutics Inc
Name
Phone
415-910-5717
Name
Address
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Name
Employee
36
Name
Twitter
Name
Next Earnings Date
2025-03-24
Name
Latest SEC Filings
Name
QNCX's Discussions on Twitter

Compare QNCX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
QNCX
Quince Therapeutics Inc
1.63 89.70M 0 -31.39M -18.45M -0.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-05-25 Initiated Citizens JMP Mkt Outperform
Mar-24-25 Initiated Oppenheimer Outperform

Quince Therapeutics Inc Stock (QNCX) Latest News

pulisher
Aug 21, 2025

Is Quince Therapeutics Inc. stock poised for growthPortfolio Update Report & Risk Controlled Swing Trade Alerts - Newser

Aug 21, 2025
pulisher
Aug 21, 2025

Quince Therapeutics Inc. stock momentum explainedJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - Newser

Aug 21, 2025
pulisher
Aug 20, 2025

Historical volatility pattern of Quince Therapeutics Inc. visualizedEarnings Summary Report & Daily Stock Momentum Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Quince Therapeutics Inc. stock prediction for this week2025 Trading Volume Trends & Fast Gain Stock Trading Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Analyzing drawdowns of Quince Therapeutics Inc. with statistical toolsLong Setup & Consistent Return Strategy Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

New Product Launches: Will They Boost Quince Therapeutics Inc. Stock in 2025July 2025 Spike Watch & Community Consensus Trade Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is this a good reentry point in Quince Therapeutics Inc.Market Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Quince Therapeutics Inc. stock chart pattern explainedJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Momentum divergence signals in Quince Therapeutics Inc. chartMarket Trend Report & Growth-Oriented Investment Plans - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Building trade automation scripts for Quince Therapeutics Inc.July 2025 Sentiment & Fast Gain Swing Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Real time social sentiment graph for Quince Therapeutics Inc.Market Sentiment Report & AI Forecast for Swing Trade Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 14:00:59 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is Quince Therapeutics Inc. a candidate for recovery playWeekly Trade Report & AI Enhanced Market Trend Forecasts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Ranking Quince Therapeutics Inc. among high performing stocks via toolsRate Hike & Scalable Portfolio Growth Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Trend Reversal Possible in Quince Therapeutics Inc. Charts IndicateQuarterly Performance Summary & Comprehensive Market Scan Insights - 선데이타임즈

Aug 19, 2025
pulisher
Aug 18, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives $8.14 Average Target Price from Brokerages - Defense World

Aug 18, 2025
pulisher
Aug 18, 2025

Is it time to cut losses on Quince Therapeutics Inc.July 2025 Review & Technical Pattern Alert System - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Should you hold or exit Quince Therapeutics Inc. nowJuly 2025 EndofMonth & Weekly Setup with High ROI Potential - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What candlestick patterns are forming on Quince Therapeutics Inc.2025 Market Trends & Detailed Earnings Play Strategies - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Quince Therapeutics Inc. Approaches Support With Recovery in SightJuly 2025 Rallies & Free Safe Capital Growth Stock Tips - beatles.ru

Aug 17, 2025
pulisher
Aug 17, 2025

Using data tools to time your Quince Therapeutics Inc. exit2025 Performance Recap & Step-by-Step Swing Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Price Channel Expanding on Quince Therapeutics Inc.’s ChartJuly 2025 Action & Weekly Top Gainers Trade List - newsyoung.net

Aug 16, 2025
pulisher
Aug 16, 2025

Exit strategy if you’re trapped in Quince Therapeutics Inc.Forecast Cut & AI Driven Stock Movement Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What Fibonacci levels say about Quince Therapeutics Inc. reboundPortfolio Performance Report & Advanced Swing Trade Entry Alerts - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Analyzing recovery setups for Quince Therapeutics Inc. investors2025 Performance Recap & AI Driven Stock Reports - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Custom strategy builders for tracking Quince Therapeutics Inc.Earnings Overview Summary & Stock Portfolio Risk Management - Newser

Aug 15, 2025

Quince Therapeutics Inc Stock (QNCX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Quince Therapeutics Inc Stock (QNCX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Thye Dirk
CEO AND CHIEF MEDICAL OFFICER
Aug 29 '24
Buy
0.69
77,500
53,475
766,941
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):